Veterinary Medicines

Fiprotec 402 mg Spot on Solution for Extra Large Dogs

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
Fiprotec 402 mg Spot on Solution for Extra Large Dogs
Fiprotec 402 mg šķīdums pilināšanai uz ādas ļoti liela auguma suņiem
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Blue pipette composed of a heat-formed shell and a film. 2 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film. 1 pipette is packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film, enclosed in an aluminium blister. 2 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film, enclosed in an aluminium blister. 1 pipette is packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film, enclosed in an aluminium blister. 3 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film, enclosed in an aluminium blister. 6 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film, enclosed in an aluminium blister. 4 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film. 6 pipettes are packed in a cardboard box
  • Blue pipette composed of a heat-formed shell and a film. 3 pipettes are packed in a cardboard box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Beaphar BV
Marketing authorisation date:
Manufacturing sites for batch release:
  • Beaphar B.V.
  • Laboratorios Calier S.A.
Responsible authority:
  • PVD
Authorisation number:
  • V/DCP/14/0025
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0274/005
Concerned member states:
  • Bulgaria
  • Cyprus
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 19/01/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 19/01/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 19/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."